首页> 外文期刊>European journal of dermatology: EJD >Topical photodynamic therapy may not be effective for actinic cheilitis despite repeated treatments
【24h】

Topical photodynamic therapy may not be effective for actinic cheilitis despite repeated treatments

机译:尽管反复治疗,局部光动力疗法对光化性唇炎可能并不有效

获取原文
获取原文并翻译 | 示例
           

摘要

As actinic cheilitis (AC) is considered a premalignant condition, proper treatment is important. Several studies have reported that many AC lesions remain after 1-2 sessions of photodynamic therapy (PDT). Therefore, we performed repeated treatments with PDT to increase the efficacy of the modality. A total of 10 cases of AC diagnosed by skin biopsy were enrolled. Informed consent was obtained from patients before the biopsy. Methyl aminolevulinate (Metvix, Gal-derma, France) was applied to the lesion with an occlusive dressing. After 3 hours, the lesion was irradiated with 37 J/cm2 of red light (Aktilite CL 128, Galderma). Eight weeks after the treatment, if clinical complete response (CR) was observed, a skin biopsy was performed. If the patient refused a skin biopsy, we only evaluated the clinical status. When a residual AC lesion was observed, we performed repeated PDT at an interval of 2-4 weeks. 6 males and 4 females were enrolled in this study and their mean age was 71.1. The average number of treatments was 4.30 ± 1.89. Five of 10 (50.0%) patients showed CR with 2-4 sessions of PDT. The average number of treatments to CR was 4.60 ± 2.60. In 5 patients who showed CR, the lesion recurred in 2 patients at 10 and 45 months after the last treatment, respectively.
机译:由于光化性唇炎(AC)被认为是一种恶性疾病,因此正确的治疗很重要。几项研究报告说,在进行1-2次光动力疗法(PDT)后仍保留许多AC病变。因此,我们对PDT进行了重复治疗,以提高治疗效果。共有10例经皮肤活检诊断为AC的病例入选。活检之前已获得患者的知情同意。用闭塞敷料将氨基乙酰丙酸甲酯(Metvix,Gal-derma,法国)施用于病灶。 3小时后,用37J / cm 2的红光(Aktilite CL 128,Galderma)照射病灶。治疗八周后,如果观察到临床完全缓解(CR),则进行皮肤活检。如果患者拒绝皮肤活检,我们只会评估临床状况。当观察到残留的AC病变时,我们以2-4周的间隔重复进行PDT。这项研究纳入了6名男性和4名女性,他们的平均年龄为71.1。平均治疗次数为4.30±1.89。 10例患者中有5例(50.0%)接受2-4次PDT治疗后出现CR。 CR的平均治疗次数为4.60±2.60。在5例显示CR的患者中,分别在最后一次治疗后10个月和45个月时有2例复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号